临床实际中应用抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的现状及疗效观察

临床实际中应用抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的现状及疗效观察

ID:36643182

大小:573.16 KB

页数:8页

时间:2019-05-13

临床实际中应用抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的现状及疗效观察_第1页
临床实际中应用抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的现状及疗效观察_第2页
临床实际中应用抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的现状及疗效观察_第3页
临床实际中应用抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的现状及疗效观察_第4页
临床实际中应用抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的现状及疗效观察_第5页
资源描述:

《临床实际中应用抗VEGF药物治疗视网膜静脉阻塞性黄斑水肿的现状及疗效观察》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、HansJournalofOphthalmology眼科学,2017,6(3),75-81PublishedOnlineSeptember2017inHans.http://www.hanspub.org/journal/hjohttps://doi.org/10.12677/hjo.2017.63013TheActualStateoftheApplicationofAnti-VEGFDrugsintheTreatmentofMacularEdemaofRetinalVeinOcclusionChangyuQiu1,YuanyuanS

2、hi1,LipingXia1,FulinGao1,YuboGong1,HongweiZhao1,ZhaoyangPan2,JunZhao1,QianqianXu1,ChunrongWu1,LingLuo11Dept.ofOphthalmology,The306HospitalofPLA,Beijing2Dept.ofTheCentralofDiseaseControlandPreventionofEquipmentDevelopmentDepartmentofPLA,BeijingthththReceived:Jul.15,2017;

3、accepted:Aug.5,2017;published:Aug.9,2017AbstractObjective:Tostudytheactualstateofanti-VEGFdrugsinthetreatmentofmacularedemaofretin-alveinocclusion.Furtheranalyseswerealsomadetoprovidefurtherguidanceforclinicaldeci-sion.Methods:Thisisaretrospectivenonrandomizedclinicalca

4、sestudy.Atotalcollectionof62eyesof61patientswithmaculaedemaofretinalveinocclusionhadbeeninvolvedinthestudy(5patientswereexcludedtolosingthefollow-up).Theage,thegender,thegeneraldiseasehistory,theintra-vitrealinjectiontimesandtheclassesofanti-VEGFdrugswereobserved.Thebes

5、tcor-rectedvisualacuity(BCVA)andthethicknessofmacularfoveawerealsoobserved.Results:Atotalof30males(31eyes)and31females(31eyes)wereincludedinthestudy,withanaverageage(58.75±19.30),ofwhichBRVO50(50eyes),CRVO11(12eyes);theproportionofpatientswithsystemicdiseasessuchasdiabe

6、teswas56.7%.Theaveragetimefromillnesstovisitrangedfrom6daysto2years;andthefrequencyofusingRanibizumabisthreetimestothatofusingConper-cept.Thepatientswithonlyoneintra-vitrealinjectionwereoccupied45.9percent.Thosewithtwoorthreeinjectionswereoccupied18and23percent.Andthose

7、withmorethanthreetimesinjectionswereoccupied13.1percent.TheaverageoftheBCVAwas4.23±0.52beforethetreat-ment,anditwas4.60±0.43attheendofthefollow-up.AllpatientsgainedincreasedBCVAbythreelinesthroughoperation.TherearestatisticaldifferencesbetweentheBCVAofpostoperationandpr

8、eoperation.Theaveragethicknessofthemacularfoveawasreducedfrom477.35±202.21micrometersto259.24±99.52micrometers

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。